Indrayani Biotech consolidated net profit declines 81.18% in the June 2025 quarter
Sales decline 7.71% to Rs 29.10 crore
Net profit of Indrayani Biotech declined 81.18% to Rs 0.16 crore in the quarter ended June 2025 as against Rs 0.85 crore during the previous quarter ended June 2024. Sales declined 7.71% to Rs 29.10 crore in the quarter ended June 2025 as against Rs 31.53 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales29.1031.53 -8 OPM %11.9618.97 -PBDT3.685.19 -29 PBT0.210.94 -78 NP0.160.85 -81Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content